DK152046C - Analogifremgangsmaade til fremstilling af 2-oxo-2,3-dihydrobenzo(b)thiophencarboxamider eller salte deraf med baser - Google Patents

Analogifremgangsmaade til fremstilling af 2-oxo-2,3-dihydrobenzo(b)thiophencarboxamider eller salte deraf med baser

Info

Publication number
DK152046C
DK152046C DK158777A DK158777A DK152046C DK 152046 C DK152046 C DK 152046C DK 158777 A DK158777 A DK 158777A DK 158777 A DK158777 A DK 158777A DK 152046 C DK152046 C DK 152046C
Authority
DK
Denmark
Prior art keywords
thiophencarboxamides
dihydrobenzo
analogue
oxo
bases
Prior art date
Application number
DK158777A
Other languages
Danish (da)
English (en)
Other versions
DK152046B (da
DK158777A (da
Inventor
Raymond Bernasconi
Pier Giorgio Ferrini
Richard Goeschke
Jacques Gosteli
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH453876A external-priority patent/CH630082A5/de
Priority claimed from CH1599476A external-priority patent/CH629797A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK158777A publication Critical patent/DK158777A/da
Publication of DK152046B publication Critical patent/DK152046B/da
Application granted granted Critical
Publication of DK152046C publication Critical patent/DK152046C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK158777A 1976-04-09 1977-04-06 Analogifremgangsmaade til fremstilling af 2-oxo-2,3-dihydrobenzo(b)thiophencarboxamider eller salte deraf med baser DK152046C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH453876A CH630082A5 (de) 1976-04-09 1976-04-09 Verfahren zur herstellung von oxothiaverbindungen.
CH453876 1976-04-09
CH1599476 1976-12-20
CH1599476A CH629797A5 (en) 1976-12-20 1976-12-20 Process for the preparation of salts of oxothia compounds

Publications (3)

Publication Number Publication Date
DK158777A DK158777A (da) 1977-10-10
DK152046B DK152046B (da) 1988-01-25
DK152046C true DK152046C (da) 1988-07-18

Family

ID=25695718

Family Applications (1)

Application Number Title Priority Date Filing Date
DK158777A DK152046C (da) 1976-04-09 1977-04-06 Analogifremgangsmaade til fremstilling af 2-oxo-2,3-dihydrobenzo(b)thiophencarboxamider eller salte deraf med baser

Country Status (27)

Country Link
US (1) US4320138A (no)
JP (1) JPS52125158A (no)
AR (3) AR218869A1 (no)
AT (1) AT357148B (no)
CA (1) CA1112248A (no)
CS (4) CS207394B2 (no)
CY (1) CY1138A (no)
DD (1) DD130659A5 (no)
DE (1) DE2713584C2 (no)
DK (1) DK152046C (no)
ES (1) ES457528A1 (no)
FI (1) FI69461C (no)
FR (1) FR2347363A1 (no)
GB (1) GB1544339A (no)
GR (1) GR70652B (no)
HK (1) HK6182A (no)
HU (1) HU180438B (no)
IE (1) IE44987B1 (no)
IL (1) IL51847A (no)
KE (1) KE3185A (no)
MY (1) MY8200244A (no)
NL (1) NL7703802A (no)
NO (1) NO146810C (no)
NZ (1) NZ183747A (no)
PL (3) PL110653B1 (no)
SE (1) SE432930B (no)
SU (4) SU795475A3 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634840A5 (de) * 1978-06-29 1983-02-28 Ciba Geigy Ag 2-oxo-2,3-dihydro-benzo(b)thiophen-verbindung und daraus hergestellte pharmazeutische praeparate.
AT392787B (de) * 1978-06-29 1991-06-10 Ciba Geigy Ag Verfahren zur herstellung des neuen n-(2-thienyl)-2-oxo-2,3-dihydro-benzo(b)thiophen-3-carboxamids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413308A (en) * 1966-09-02 1968-11-26 Dow Chemical Co Substituted benzo(b)thiophene-2-carboxanilides
US3655693A (en) * 1969-06-25 1972-04-11 Merck & Co Inc Anti-inflammatory salicyclic acid derivatives
US3676463A (en) * 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3971814A (en) * 1972-11-27 1976-07-27 Warner-Lambert Company Benzo(b)thiophene derivatives
GB1571847A (en) * 1974-01-02 1980-07-23 Systems Eng & Mfg Waste water treatment

Also Published As

Publication number Publication date
IE44987B1 (en) 1982-06-02
CY1138A (en) 1982-05-07
DD130659A5 (de) 1978-04-19
SE7704033L (sv) 1977-10-10
ES457528A1 (es) 1978-08-16
FI69461B (fi) 1985-10-31
NZ183747A (en) 1979-01-11
IL51847A (en) 1981-09-13
IE44987L (en) 1977-10-09
NL7703802A (nl) 1977-10-11
HU180438B (en) 1983-03-28
GR70652B (no) 1982-12-03
PL111456B1 (en) 1980-08-30
PL110653B1 (en) 1980-07-31
SU898956A3 (ru) 1982-01-15
CS207392B2 (en) 1981-07-31
CS207395B2 (en) 1981-07-31
ATA248577A (de) 1979-11-15
PL111459B1 (en) 1980-08-30
SU795475A3 (ru) 1981-01-07
AR218869A1 (es) 1980-07-15
SE432930B (sv) 1984-04-30
CS207393B2 (en) 1981-07-31
JPS52125158A (en) 1977-10-20
CA1112248A (en) 1981-11-10
NO146810B (no) 1982-09-06
HK6182A (en) 1982-02-19
CS207394B2 (en) 1981-07-31
AR224614A1 (es) 1981-12-30
PL197311A1 (pl) 1978-01-16
FR2347363A1 (fr) 1977-11-04
DE2713584A1 (de) 1977-10-20
JPS6218556B2 (no) 1987-04-23
FI771044A (no) 1977-10-10
SU791239A3 (ru) 1980-12-23
DK152046B (da) 1988-01-25
IL51847A0 (en) 1977-06-30
GB1544339A (en) 1979-04-19
AR225401A1 (es) 1982-03-31
FI69461C (fi) 1986-02-10
DE2713584C2 (de) 1986-09-04
SU738510A3 (ru) 1980-05-30
FR2347363B1 (no) 1979-03-09
US4320138A (en) 1982-03-16
DK158777A (da) 1977-10-10
MY8200244A (en) 1982-12-31
NO146810C (no) 1982-12-15
KE3185A (en) 1982-04-02
NO771231L (no) 1977-10-11
AT357148B (de) 1980-06-25

Similar Documents

Publication Publication Date Title
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK149111C (da) Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK148117C (da) Analogifremgangsmaade til fremstilling af 2-(2-thenoylthio)-propionylglycin eller farmakologisk acceptable salte deraf med baser
DK520077A (da) Fremgangsmaade til fremstilling af 5-(hydroxysubstitueret-methhyl)-2,3-dihydrobenzofuran-2-carboxylsyrer eller salte estere eller amider deraf
DK146160C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
DK148233C (da) Analogifremgangsmaade til fremstilling af 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)benzodiazepin-6-oner, der er substitueret i 11-stillingen, eller salte deraf
DK76578A (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK156066C (da) Analogifremgangsmaade til fremstilling af oxaloamino- eller hydroxyacetylaminobenzopyranderivater eller salte deraf med baser
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK144033C (da) Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK151957C (da) Analogifremgangsmaade til fremstilling af 3-substituerede 2-oxo-1-benzimidazolinalkansyrer eller estere eller amider deraf eller salte deraf med baser
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK147198C (da) Analogifremgangsmaade til fremstilling af 9-hydroxyethoxymethylguanin-monophosphat eller salte deraf
DK152046C (da) Analogifremgangsmaade til fremstilling af 2-oxo-2,3-dihydrobenzo(b)thiophencarboxamider eller salte deraf med baser
DK143403C (da) Analogifremgangsmaade til fremstilling af 8-(1h-tetrazol-5-yl)-11h-pyrido(2,1-b)quinazolin-11-oner eller salte deraf
DK164786C (da) Analogifremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK143752C (da) Analogifremgangsmaade til fremstilling af pyridobenzodiazepinoner eller farmakologisk acceptable salte deraf
DK144822C (da) Analogifremgangsmaade til fremstilling af hoejredrejende 7-brom-6-chlor-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4-3h-quinazolinon eller dets additionssalte med syrer

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed